Clinical Scorecard: Remote OCT Protocol to Speed Diagnosis and Treatment of CRAO
At a Glance
| Category | Detail |
|---|---|
| Condition | Central Retinal Artery Occlusion (CRAO), an ophthalmic emergency causing acute painless monocular vision loss |
| Key Mechanisms | Retinal ischemia diagnosed by OCT showing inner retinal hyperreflectivity, thickening, loss of layer distinction, and characteristic foveal glow; treatment with intravenous or intra-arterial tissue plasminogen activator (tPA) |
| Target Population | Patients presenting with acute painless monocular vision loss within 24 hours, primarily in emergency department settings |
| Care Setting | Emergency departments and stroke centers utilizing remote consult protocols with OCT imaging and stroke neurology collaboration |
Key Highlights
- Remote consult protocol using macular OCT enables rapid diagnosis of CRAO without in-person ophthalmology consults
- Treatment with intravenous or intra-arterial tPA within 4.5 hours of last known well improves visual outcomes
- Implementation reduced door-to-treatment time by over 2 hours and resulted in significant visual acuity improvement in treated patients
Guideline-Based Recommendations
Diagnosis
- Activate stroke code for patients with acute painless monocular vision loss
- Perform focused history and physical exam by stroke neurology
- Acquire macular OCT scans of both eyes to identify inner retinal hyperreflectivity, thickening, loss of layer distinction, and foveal glow
- Transfer OCT images remotely to ophthalmology team for confirmation of CRAO
Management
- Administer intravenous tPA if within 4.5 hours of last known well
- Consider cerebral angiography with intra-arterial tPA injection into ophthalmic artery in eligible patients
- Intra-arterial tPA dosing: 2 mg increments every 5 minutes until visual improvement, choroidal blush restoration, or max 22 mg
- Admit all patients for stroke evaluation regardless of treatment
Monitoring & Follow-up
- Monitor visual acuity improvements within 24 hours and at 1 month post-treatment
- Observe for reocclusion and persistent vision loss
- Monitor for systemic complications including intracranial hemorrhage
Risks
- Potential for reocclusion causing persistent vision loss
- No intracranial hemorrhages or systemic complications observed in initial study
Patient & Prescribing Data
Patients presenting with acute painless monocular vision loss diagnosed with CRAO
Of patients meeting treatment criteria, 90% received intra-arterial tPA with mean dose 16 mg; 66% improved from worse than 20/200 to 20/100 or better within 24 hours; 44% improved to 20/40 or better
Clinical Best Practices
- Ensure collaboration and buy-in across ophthalmology, emergency, and stroke services
- Place OCT machines in accessible locations near stroke and emergency facilities
- Use user-friendly OCT devices operable by non-experts
- Eliminate unnecessary diagnostic testing to streamline workflow
- Establish redundant communication systems to ensure timely ophthalmology response
References
- Incidence and presentation of CRAO
- Diagnostic features of CRAO
- Stroke risk and management in CRAO
- Remote OCT protocol study and outcomes
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







